Skip to main content
Top
Published in: International Journal of Clinical Oncology 4/2009

01-08-2009 | Case Report

Octreotide acetate successfully treated a bowel obstruction caused by peritoneally disseminated gastric cancer, thereby enabling the subsequent use of oral S-1 chemotherapy

Authors: Koshi Kumagai, Yoshiro Saikawa, Kazumasa Fukuda, Ryo Ito, Takahiro Igarashi, Shinichi Tsuwano, Rieko Nakamura, Tsunehiro Takahashi, Hiroya Takeuchi, Yuko Kitagawa

Published in: International Journal of Clinical Oncology | Issue 4/2009

Login to get access
Metadata
Title
Octreotide acetate successfully treated a bowel obstruction caused by peritoneally disseminated gastric cancer, thereby enabling the subsequent use of oral S-1 chemotherapy
Authors
Koshi Kumagai
Yoshiro Saikawa
Kazumasa Fukuda
Ryo Ito
Takahiro Igarashi
Shinichi Tsuwano
Rieko Nakamura
Tsunehiro Takahashi
Hiroya Takeuchi
Yuko Kitagawa
Publication date
01-08-2009
Publisher
Springer Japan
Published in
International Journal of Clinical Oncology / Issue 4/2009
Print ISSN: 1341-9625
Electronic ISSN: 1437-7772
DOI
https://doi.org/10.1007/s10147-008-0886-8

Other articles of this Issue 4/2009

International Journal of Clinical Oncology 4/2009 Go to the issue

Introduction to Review Articles

Treatment of metastatic brain tumors

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine